[ 1 ] Dubey JP, Schares G, Ortega-Mora LM. Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev 2007;20(2):323–67. link1

[ 2 ] Dubey JP, Hattel AL, Lindsay DS, Topper MJ. Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J Am Vet Med Assoc 1988;193(10):1259–63. link1

[ 3 ] Dubey JP, Hemphill A, Calero-Bernal R, Schares G. Neosporosis in animals. Boca Raton: CRC Press; 2017. link1

[ 4 ] Bjerkås I, Mohn SF, Presthus J. Unidentified cyst-forming sporozoon causing encephalomyelitis and myositis in dogs. Z Parasitenkd 1984;70(2):271–4. link1

[ 5 ] McAllister MM, Dubey JP, Lindsay DS, Jolley WR, Wills RA, McGuire AM. Dogs are definitive hosts of Neospora caninum. Int J Parasitol 1998;28(9):1473–9. link1

[ 6 ] Gondim LF, McAllister MM, Pitt WC, Zemlicka DE. Coyotes (Canis latrans) are definitive hosts of Neospora caninum. Int J Parasitol 2004;34(2):159–61. link1

[ 7 ] Dubey JP, Jenkins MC, Rajendran C, Miska K, Ferreira LR, Martins J, et al. Gray wolf (Canis lupus) is a natural definitive host for Neospora caninum. Vet Parasitol 2011;181(2–4):382–7. link1

[ 8 ] King JS, Slapeta J, Jenkins DJ, Al-Qassab SE, Ellis JT, Windsor PA. Australian dingoes are definitive hosts of Neospora caninum. Int J Parasitol 2010;40 (8):945–50. link1

[ 9 ] Ojo KK, Reid MC, Kallur Siddaramaiah L, Müller J, Winzer P, Zhang Z, et al. Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy. PLoS ONE 2014;9(3):e92929. link1

[10] Dubey JP. Recent advances in Neospora and neosporosis. Vet Parasitol 1999;84(3–4):349–67. link1

[11] Dubey JP. Neosporosis in cattle: biology and economic impact. J Am Vet Med Assoc 1999;214(8):1160–3. link1

[12] Dubey JP, Ferguson DJ. Life cycle of Hammondia hammondi (Apicomplexa: Sarcocystidae) in cats. J Eukaryot Microbiol 2015;62(3):346–52. link1

[13] Pare J, Thurmond MC, Hietala SK. Congenital Neospora caninum infection in dairy cattle and associated calfhood mortality. Can J Veter Res 1996;60:133–9. link1

[14] Thurmond MC, Hietala SK. Effect of congenitally acquired Neospora caninum infection on risk of abortion and subsequent abortions in dairy cattle. Am J Vet Res 1997;58(12):1381–5. link1

[15] Marsh AE, Barr BC, Packham AE, Conrad PA. Description of a new Neospora species (Protozoa: Apicomplexa: Sarcocystidae). J Parasitol 1998;84 (5):983–91. link1

[16] Marsh AE, Howe DK, Wang G, Barr BC, Cannon N, Conrad PA. Differentiation of Neospora hughesi from Neospora caninum based on their immunodominant surface antigen, SAG1 and SRS2. Int J Parasitol 1999;29(10):1575–82. link1

[17] Fernández-García A, Risco-Castillo V, Zaballos A, Alvarez-García G, OrtegaMora LM. Identification and molecular cloning of the Neospora caninum SAG4 gene specifically expressed at bradyzoite stage. Mol Biochem Parasitol 2006;146(1):89–97. link1

[18] Walsh CP, Vemulapalli R, Sriranganathan N, Zajac AM, Jenkins MC, Lindsay DS. Molecular comparison of the dense granule proteins GRA6 and GRA7 of Neospora hughesi and Neospora caninum. Int J Parasitol 2001;31(3):253–8. link1

[19] Dubey JP, Liddell S, Mattson D, Speer CA, Howe DK, Jenkins MC. Characterization of the Oregon isolate of Neospora hughesi from a horse. J Parasitol 2001;87(2):345–53. link1

[20] Dubey JP, Lindsay DS. Gerbils (Meriones unguiculatus) are highly susceptible to oral infection with Neospora caninum oocysts. Parasitol Res 2000;86 (2):165–8. link1

[21] Romano A, Inbar E, Debrabant A, Charmoy M, Lawyer P, Ribeiro-Gomes F, et al. Cross-species genetic exchange between visceral and cutaneous strains of Leishmania in the sand fly vector. Proc Natl Acad Sci USA 2014;111 (47):16808–13. link1

[22] Cole RA, Lindsay DS, Dubey JP, Toivio-Kinnucan MA, Blagburn BL. Characterization of a murine monoclonal antibody generated against Neospora caninum tachyzoites by use of western blot analysis and immunoelectron microscopy. Am J Vet Res 1994;55(12):1717–22. link1

[23] Lindsay DS, Dubey JP. Immunohistochemical diagnosis of Neospora caninum in tissue sections. Am J Vet Res 1989;50(11):1981–3. link1

[24] Uzêda RS, Schares G, Ortega-Mora LM, Madruga CR, Aguado-Martinez A, Corbellini LG, et al. Combination of monoclonal antibodies improves immunohistochemical diagnosis of Neospora caninum. Vet Parasitol 2013;197(3–4):477–86. link1

[25] McGiff JC, Laniado-Schwartzman M. Arachidonic acid metabolites and blood pressure control. Clin Physiol Biochem 1988;6(3–4):179–87. link1

[26] Trees AJ, Guy F, Tennant BJ, Balfour AH, Dubey JP. Prevalence of antibodies to Neospora caninum in a population of urban dogs in England. Vet Rec 1993;132 (6):125–6. link1

[27] Dubey JP, Lindsay DS, Adams DS, Gay JM, Baszler TV, Blagburn BL, et al. Serologic responses of cattle and other animals infected with Neospora caninum. Am J Vet Res 1996;57(3):329–36. link1

[28] Packham AE, Sverlow KW, Conrad PA, Loomis EF, Rowe JD, Anderson ML, et al. A modified agglutination test for Neospora caninum: development, optimization, and comparison to the indirect fluorescent-antibody test and enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 1998;5 (4):467–73. link1

[29] Romand S, Thulliez P, Dubey JP. Direct agglutination test for serologic diagnosis of Neospora caninum infection. Parasitol Res 1997;84(1):50–3. link1

[30] Sinnott FA, Monte LG, Collares TF, Silveira RM, Borsuk S. Review on the immunological and molecular diagnosis of neosporosis (years 2011–2016). Vet Parasitol 2017;239:19–25. link1

[31] Von Blumröder D, Schares G, Norton R, Williams DJ, Esteban-Redondo I, Wright S, et al. Comparison and standardisation of serological methods for the diagnosis of Neospora caninum infection in bovines. Vet Parasitol 2004;120(1–2):11–22. link1

[32] Williams DJ, Davison HC, Helmick B, McGarry J, Guy F, Otter A, et al. Evaluation of a commercial ELISA for detecting serum antibody to Neospora caninum in cattle. Vet Rec 1999;145(20):571–5. link1

[33] Ybañez RH, Terkawi MA, Kameyama K, Xuan X, Nishikawa Y. Identification of a highly antigenic region of subtilisin-like serine protease 1 for serodiagnosis of Neospora caninum infection. Clin Vaccine Immunol 2013;20(10):1617–22. link1

[34] Ghalmi F, China B, Kaidi R, Losson B. Evaluation of a SRS2 sandwich commercial enzyme-linked immunosorbent assay for the detection of antiNeospora caninum antibodies in bovine and canine sera. J Vet Diagn Invest 2009;21(1):108–11. link1

[35] Baszler TV, Adams S, Vander-Schalie J, Mathison BA, Kostovic M. Validation of a commercially available monoclonal antibody-based competitive-inhibition enzyme-linked immunosorbent assay for detection of serum antibodies to Neospora caninum in cattle. J Clin Microbiol 2001;39(11):3851–7. link1

[36] Ghalmi F, China B, Jenkins M, Azzag N, Losson B. Comparison of different serological methods to detect antibodies specific to Neospora caninum in bovine and canine sera. J Vet Diagn Invest 2014;26(1):136–40. link1

[37] Moraveji M, Hosseini A, Moghaddar N, Namavari MM, Eskandari MH. Development of latex agglutination test with recombinant NcSAG1 for the rapid detection of antibodies to Neospora caninum in cattle. Vet Parasitol 2012;189(2–4):211–7. link1

[38] Hu J, Ferroglio E, Trisciuoglio A. Immunoblot diagnosis of infection with Neospora caninum in cattle based on recombinant NcSAG4 antigen. Parasitol Res 2011;108(4):1055–8. link1

[39] Rosypal AC, Lindsay DS. The sylvatic cycle of Neospora caninum: where do we go from here? Trends Parasitol 2005;21(10):439–40. link1

[40] Nam HW, Kang SW, Choi WY. Antibody reaction of human anti-Toxoplasma gondii positive and negative sera with Neospora caninum antigens. Korean J Parasitol 1998;36(4):269–75. link1

[41] Petersen E, Lebech M, Jensen L, Lind P, Rask M, Bagger P, et al. Neospora caninum infection and repeated abortions in humans. Emerg Infect Dis 1999;5(2):278–80. link1

[42] Lobato J, Silva DA, Mineo TW, Amaral JD, Segundo GR, Costa-Cruz JM, et al. Detection of immunoglobulin G antibodies to Neospora caninum in humans: high seropositivity rates in patients who are infected by human immunodeficiency virus or have neurological disorders. Clin Vaccine Immunol 2006;13(1):84–9. link1

[43] Marsh AE, Barr BC, Sverlow K, Ho M, Dubey JP, Conrad PA. Sequence analysis and comparison of ribosomal DNA from bovine Neospora to similar coccidial parasites. J Parasitol 1995;81(4):530–5. link1

[44] Stenlund S, Björkman C, Holmdahl OJ, Kindahl H, Uggla A. Characterization of a Swedish bovine isolate of Neospora caninum. Parasitol Res 1997;83 (3):214–9. link1

[45] Lindsay DS, Dubey JP. Evaluation of anti-coccidial drugs’ inhibition of Neospora caninum development in cell cultures. J Parasitol 1989;75(6):990–2. link1

[46] Ho MS, Barr BC, Marsh AE, Anderson ML, Rowe JD, Tarantal AF, et al. Identification of bovine Neospora parasites by PCR amplification and specific small-subunit rRNA sequence probe hybridization. J Clin Microbiol 1996;34 (5):1203–8. link1

[47] Ellis JT. Polymerase chain reaction approaches for the detection of Neospora caninum and Toxoplasma gondii. Int J Parasitol 1998;28(7):1053–60. link1

[48] Magnino S, Vigo PG, Fabbi M, Colombo M, Bandi C, Genchi C. Isolation of a bovine Neospora from a newborn calf in Italy. Vet Rec 1999;144(16):456. link1

[49] Ellis JT, McMillan D, Ryce C, Payne S, Atkinson R, Harper PA. Development of a single tube nested polymerase chain reaction assay for the detection of Neospora caninum DNA. Int J Parasitol 1999;29(10):1589–96. link1

[50] Gondim LF, Laski P, Gao L, McAllister MM. Variation of the internal transcribed spacer 1 sequence within individual strains and among different strains of Neospora caninum. J Parasitol 2004;90(1):119–22. link1

[51] Dubey JP, Vianna MC, Kwok OC, Hill DE, Miska KB, Tuo W, et al. Neosporosis in Beagle dogs: clinical signs, diagnosis, treatment, isolation and genetic characterization of Neospora caninum. Vet Parasitol 2007;149(3–4):158–66. link1

[52] Muradian V, Ferreira LR, Lopes EG, De Oliveira Esmerini P, De Jesus Pena HF, Soares RM, et al. A survey of Neospora caninum and Toxoplasma gondii infection in urban rodents from Brazil. J Parasitol 2012;98(1):128–34. link1

[53] McInnes LM, Irwin P, Palmer DG, Ryan UM. In vitro isolation and characterisation of the first canine Neospora caninum isolate in Australia. Vet Parasitol 2006;137(3–4):355–63. link1

[54] Siverajah S, Ryce C, Morrison DA, Ellis JT. Characterization of an alpha tubulin gene sequence from Neospora caninum and Hammondia heydorni, and their comparison to homologous genes from Apicomplexa. Parasitology 2003;126 (Pt 6):561–9. link1

[55] Regidor-Cerrillo J, Pedraza-Díaz S, Gómez-Bautista M, Ortega-Mora LM. Multilocus microsatellite analysis reveals extensive genetic diversity in Neospora caninum. J Parasitol 2006;92(3):517–24. link1

[56] Basso W, Schares S, Bärwald A, Herrmann DC, Conraths FJ, Pantchev N, et al. Molecular comparison of Neospora caninum oocyst isolates from naturally infected dogs with cell culture-derived tachyzoites of the same isolates using nested polymerase chain reaction to amplify microsatellite markers. Vet Parasitol 2009;160(1–2):43–50. link1

[57] Regidor-Cerrillo J, Díez-Fuertes F, García-Culebras A, Moore DP, GonzálezWarleta M, Cuevas C, et al. Genetic diversity and geographic population structure of bovine Neospora caninum determined by microsatellite genotyping analysis. PLoS One 2013;8(8):e72678. link1

[58] Adams RI, Brown KM, Hamilton MB. The impact of microsatellite electromorph size homoplasy on multilocus population structure estimates in a tropical tree (Corythophora alta) and an anadromous fish (Morone saxatilis). Mol Ecol 2004;13(9):2579–88 link1

[59] Hu Z, Weng X, Xu C, Lin Y, Cheng C, Wei H, et al. Metagenomic nextgeneration sequencing as a diagnostic tool for toxoplasmic encephalitis. Ann Clin Microbiol Antimicrob 2018;17(1):45. link1

[60] DeBarry JD, Kissinger JC. Jumbled genomes: missing Apicomplexan synteny. Mol Biol Evol 2011;28(10):2855–71. link1

[61] Reid AJ, Vermont SJ, Cotton JA, Harris D, Hill-Cawthorne GA, Könen-Waisman S, et al. Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum: Coccidia differing in host range and transmission strategy. PLoS Pathog 2012;8(3):e1002567. link1

[62] Lorenzi H, Khan A, Behnke MS, Namasivayam S, Swapna LS, Hadjithomas M, et al. Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes. Nat Commun 2016;7(1):10147. link1

[63] Ricklefs RE, Outlaw DC. A molecular clock for malaria parasites. Science 2010;329(5988):226–9. link1

[64] Ramaprasad A, Mourier T, Naeem R, Malas TB, Moussa E, Panigrahi A, et al. Comprehensive evaluation of Toxoplasma gondii VEG and Neospora caninum LIV genomes with tachyzoite stage transcriptome and proteome defines novel transcript features. PLoS One 2015;10(4):e0124473. link1

[65] Howe DK, Sibley LD. Development of molecular genetics for Neospora caninum: a complementary system to Toxoplasma gondii. Methods 1997;13 (2):123–33. link1

[66] Howe DK, Mercier C, Messina M, Sibley LD. Expression of Toxoplasma gondii genes in the closely-related apicomplexan parasite Neospora caninum. Mol Biochem Parasitol 1997;86(1):29–36. link1

[67] Beckers CJ, Wakefield T, Joiner KA. The expression of Toxoplasma proteins in Neospora caninum and the identification of a gene encoding a novel rhoptry protein. Mol Biochem Parasitol 1997;89(2):209–23. link1

[68] Zhang G, Huang X, Boldbaatar D, Battur B, Battsetseg B, Zhang H, et al. Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice. Vaccine 2010;28(45):7243–7. link1

[69] Pereira LM, Baroni L, Yatsuda AP. A transgenic Neospora caninum strain based on mutations of the dihydrofolate reductase-thymidylate synthase gene. Exp Parasitol 2014;138:40–7. link1

[70] Pereira LM, Yatsuda AP. The chloramphenicol acetyltransferase vector as a tool for stable tagging of Neospora caninum. Mol Biochem Parasitol 2014;196 (2):75–81. link1

[71] Arranz-Solís D, Regidor-Cerrillo J, Lourido S, Ortega-Mora LM, Saeij JPJ. Toxoplasma CRISPR/Cas9 constructs are functional for gene disruption in Neospora caninum. Int J Parasitol 2018;48(8):597–600. link1

[72] Romero JJ, Pérez E, Frankena K. Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions. Vet Parasitol 2004;123(3–4):149–59. link1

[73] Naguleswaran A, Cannas A, Keller N, Vonlaufen N, Björkman C, Hemphill A. Vero cell surface proteoglycan interaction with the microneme protein NcMIC(3) mediates adhesion of Neospora caninum tachyzoites to host cells unlike that in Toxoplasma gondii. Int J Parasitol 2002;32(6):695–704. link1

[74] Vonlaufen N, Guetg N, Naguleswaran A, Müller N, Björkman C, Schares G, et al. In vitro induction of Neospora caninum bradyzoites in Vero cells reveals differential antigen expression, localization, and host-cell recognition of tachyzoites and bradyzoites. Infect Immun 2004;72(1):576–83. link1

[75] English ED, Adomako-Ankomah Y, Boyle JP. Secreted effectors in Toxoplasma gondii and related species: determinants of host range and pathogenesis? Parasite Immunol 2015;37(3):127–40. link1

[76] Hemphill A, Gajendran N, Sonda S, Fuchs N, Gottstein B, Hentrich B, et al. Identification and characterisation of a dense granule-associated protein in Neospora caninum tachyzoites. Int J Parasitol 1998;28(3):429–38. link1

[77] Hemphill A, Vonlaufen N, Naguleswaran A. Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum. Parasitology 2006;133(Pt 03):261–78. link1

[78] Naguleswaran A, Müller N, Hemphill A. Neospora caninum and Toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions. Exp Parasitol 2003;104(3–4):149–58. link1

[79] Louie K, Nordhausen R, Robinson TW, Barr BC, Conrad PA. Characterization of Neospora caninum protease, NcSUB1 (NC-P65), with rabbit anti-N54. J Parasitol 2002;88(6):1113–9. link1

[80] Taylor S, Barragan A, Su C, Fux B, Fentress SJ, Tang K, et al. A secreted serinethreonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 2006;314(5806):1776–80. link1

[81] Saeij JPJ, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 2006;314(5806):1780–3. link1

[82] Fentress SJ, Behnke MS, Dunay IR, Mashayekhi M, Rommereim LM, Fox BA, et al. Phosphorylation of immunity-related GTPases by a parasite secretory kinase promotes macrophage survival and virulence. Cell Host Microbe 2010;8(6):484–95. link1

[83] Fentress SJ, Sibley LD. The secreted kinase ROP18 defends Toxoplasma’s border. BioEssays 2011;33(9):693–700. link1

[84] Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, Sibley LD. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci USA 2011;108(23):9631–6. link1

[85] Behnke MS, Khan A, Lauron EJ, Jimah JR, Wang Q, Tolia NH, et al. Rhoptry proteins ROP5 and ROP18 are major murine virulence factors in genetically divergent South American strains of Toxoplasma gondii. PLoS Genet 2015;11 (8):e1005434. link1

[86] Reese ML, Boothroyd JC. A conserved non-canonical motif in the pseudoactive site of the ROP5 pseudokinase domain mediates its effect on Toxoplasma virulence. J Biol Chem 2011;286(33):29366–75. link1

[87] Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci USA 2011;108(23):9625–30. link1

[88] Etheridge RD, Alaganan A, Tang K, Lou HJ, Turk BE, Sibley LD. The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. Cell Host Microbe 2014;15 (5):537–50. link1

[89] Khan A, Taylor S, Ajioka JW, Rosenthal BM, Sibley LD. Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice. PLoS Genet 2009;5(3):e1000404. link1

[90] Lei T, Wang H, Liu J, Nan H, Liu Q. ROP18 is a key factor responsible for virulence difference between Toxoplasma gondii and Neospora caninum. PLoS One 2014;9(6):e99744. link1

[91] Baszler TV, Long MT, McElwain TF, Mathison BA. Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice. Int J Parasitol 1999;29(10):1635–46. link1

[92] Nishikawa Y, Tragoolpua K, Inoue N, Makala L, Nagasawa H, Otsuka H, et al. In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages. Clin Diagn Lab Immunol 2001;8 (4):811–6. link1

[93] Spekker K, Leineweber M, Degrandi D, Ince V, Brunder S, Schmidt SK, et al. Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs). Med Microbiol Immunol 2013;202(3):197–206. link1

[94] Beiting DP, Peixoto L, Akopyants NS, Beverley SM, Wherry EJ, Christian DA, et al. Differential induction of TLR3-dependent innate immune signaling by closely related parasite species. PLoS One 2014;9(2):e88398. link1

[95] Saeij JPJ, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 2007;445(7125):324–7. link1

[96] Hunter CA, Sibley LD. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol 2012;10(11):766–78. link1

[97] Ma L, Liu G, Liu J, Li M, Zhang H, Tang D, et al. Neospora caninum ROP16 play an important role in the pathogenicity by phosphorylating host cell STAT3. Vet Parasitol 2017;243:135–47. link1

[98] Mercier C, Cesbron-Delauw MF. Toxoplasma secretory granules: one population or more? Trends Parasitol 2015;31(2):60–71. link1

[99] Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, Jensen KD, et al. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med 2011;208(1):195–212. link1

[100] Bougdour A, Durandau E, Brenier-Pinchart MP, Ortet P, Barakat M, Kieffer S, et al. Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression. Cell Host Microbe 2013;13(4):489–500. link1

[101] Braun L, Brenier-Pinchart MP, Yogavel M, Curt-Varesano A, Curt-Bertini RL, Hussain T, et al. A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation. J Exp Med 2013;210(10):2071–86. link1

[102] Lally N, Jenkins M, Liddell S, Dubey JP. A dense granule protein (NCDG1) gene from Neospora caninum. Mol Biochem Parasitol 1997;87(2):239–43. link1

[103] Liddell S, Lally NC, Jenkins MC, Dubey JP. Isolation of the cDNA encoding a dense granule associated antigen (NCDG2) of Neospora caninum. Mol Biochem Parasitol 1998;93(1):153–8. link1

[104] Pastor-Fernández I, Regidor-Cerrillo J, Álvarez-García G, Marugán-Hernández V, García-Lunar P, Hemphill A, et al. The tandemly repeated NTPase (NTPDase) from Neospora caninum is a canonical dense granule protein whose RNA expression, protein secretion and phosphorylation coincides with the tachyzoite egress. Parasit Vectors 2016;9(1):352. link1

[105] Atkinson R, Harper PA, Ryce C, Morrison DA, Ellis JT. Comparison of the biological characteristics of two isolates of Neospora caninum. Parasitology 1999;118(Pt 4):363–70. link1

[106] Miller CM, Quinn HE, Windsor PA, Ellis JT. Characterisation of the first Australian isolate of Neospora caninum from cattle. Aust Vet J 2002;80 (10):620–5. link1

[107] Lindsay DS, Lenz SD, Cole RA, Dubey JP, Blagburn BL. Mouse model for central nervous system Neospora caninum infections. J Parasitol 1995;81 (2):313–5. link1

[108] Regidor-Cerrillo J, Álvarez-García G, Pastor-Fernández I, Marugán-Hernández V, Gómez-Bautista M, Ortega-Mora LM. Proteome expression changes among virulent and attenuated Neospora caninum isolates. J Proteomics 2012;75 (8):2306–18. link1

[109] Regidor-Cerrillo J, García-Lunar P, Pastor-Fernández I, Álvarez-García G, Collantes-Fernández E, Gómez-Bautista M, et al. Neospora caninum tachyzoite immunome study reveals differences among three biologically different isolates. Vet Parasitol 2015;212(3–4):92–9. link1

[110] Reichel MP, Alejandra Ayanegui-Alcérreca M, Gondim LF, Ellis JT. What is the global economic impact of Neospora caninum in cattle the billion dollar question. Int J Parasitol 2013;43(2):133–42. link1

[111] Weston JF, Heuer C, Williamson NB. Efficacy of a Neospora caninum killed tachyzoite vaccine in preventing abortion and vertical transmission in dairy cattle. Prev Vet Med 2012;103(2–3):136–44. link1

[112] Mansilla FC, Moore DP, Quintana ME, Cardoso N, Hecker YP, Gual I, et al. Safety and immunogenicity of a soluble native Neospora caninum tachyzoite-extract vaccine formulated with a soy lecithin/b-glucan adjuvant in pregnant cattle. Vet Immunol Immunopathol 2015;165(1–2): 75–80. link1

[113] Weber FH, Jackson JA, Sobecki B, Choromanski L, Olsen M, Meinert T, et al. On the efficacy and safety of vaccination with live tachyzoites of Neospora caninum for prevention of neospora-associated fetal loss in cattle. Clin Vaccine Immunol 2013;20(1):99–105. link1

[114] Rojo-Montejo S, Collantes-Fernández E, Pérez-Zaballos F, Rodríguez-Marcos S, Blanco-Murcia J, Rodríguez-Bertos A, et al. Effect of vaccination of cattle with the low virulence Nc-Spain 1H isolate of Neospora caninum against a heterologous challenge in early and mid-gestation. Vet Res 2013;44 (1):106. link1

[115] Hecker YP, Moore DP, Quattrocchi V, Regidor-Cerrillo J, Verna A, Leunda MR, et al. Immune response and protection provided by live tachyzoites and native antigens from the NC-6 Argentina strain of Neospora caninum in pregnant heifers. Vet Parasitol 2013;197(3–4):436–46. link1

[116] Reichel MP, Moore DP, Hemphill A, Ortega-Mora LM, Dubey JP, Ellis JT. A live vaccine against Neospora caninum abortions in cattle. Vaccine 2015;33 (11):1299–301. link1

[117] Nishimura M, Kohara J, Kuroda Y, Hiasa J, Tanaka S, Muroi Y, et al. Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to Neospora caninum in cattle. Vaccine 2013;31 (35):3528–35. link1

[118] Hecker YP, Cóceres V, Wilkowsky SE, Jaramillo Ortiz JM, Morrell EL, Verna AE, et al. A Neospora caninum vaccine using recombinant proteins fails to prevent foetal infection in pregnant cattle after experimental intravenous challenge. Vet Immunol Immunopathol 2014;162(3–4):142–53. link1

[119] Wang JL, Li TT, Elsheikha HM, Chen K, Cong W, Yang WB, et al. Live attenuated Pru: Dcdpk2 strain of Toxoplasma gondii protects against acute, chronic, and congenital toxoplasmosis. J Infect Dis 2018;218(5):768–77. link1